AQUEDUCTAL STENOSIS

AQUEDUCTAL STENOSIS was reported 38 times

AQUEDUCTAL STENOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Protease Inhibitor [EPC] 7 0.0002
1 Cytochrome P450 3A Inhibitor [EPC] 7 0.0001
2 Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] 1 0.0001
3 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
4 Bile Acid Sequestrant [EPC] 1 0.0001
5 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0001
6 Parenteral Iron Replacement [EPC] 1 0.0001
7 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
8 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0000
9 Muscle Relaxant [EPC] 1 0.0000
10 Purine Antimetabolite [EPC] 2 0.0000
11 HER2/neu Receptor Antagonist [EPC] 1 0.0000
12 Integrin Receptor Antagonist [EPC] 1 0.0000
13 gamma-Aminobutyric Acid-ergic Agonist [EPC] 1 0.0000
14 Aminosalicylate [EPC] 1 0.0000
15 Antirheumatic Agent [EPC] 1 0.0000
16 Sulfonylurea [EPC] 1 0.0000
17 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
18 Prostacycline Vasodilator [EPC] 1 0.0000
19 Calcium [EPC] 1 0.0000
20 Microtubule Inhibitor [EPC] 1 0.0000
21 Interferon beta [EPC] 1 0.0000
22 Endothelin Receptor Antagonist [EPC] 1 0.0000
23 Expectorant [EPC] 1 0.0000
24 Atypical Antipsychotic [EPC] 2 0.0000
25 Retinoid [EPC] 1 0.0000
26 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
27 Factor Xa Inhibitor [EPC] 1 0.0000
28 Vitamin D [EPC] 1 0.0000
29 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
30 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
31 Vitamin B12 [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
33 Vitamin C [EPC] 1 0.0000
34 Corticosteroid [EPC] 2 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000